Former FDA Director Eric Karikari-Boateng joins Bio Usawa to lead its global regulatory strategy.
Bio Usawa, Inc., a leading biotechnology company committed to delivering affordable and accessible monoclonal antibody-based therapies for cancer, ophthalmic, autoimmune, ...
